<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Gufic Biosciences Limited — News on 6ix</title>
    <link>https://6ix.com/company/gufic-biosciences-limited</link>
    <description>Latest news and press releases for Gufic Biosciences Limited on 6ix.</description>
    <language>en-us</language>
    <lastBuildDate>Mon, 11 Sep 2023 22:32:56 GMT</lastBuildDate>
    <generator>6ix RSS</generator>
    <atom:link href="https://6ix.com/rss/company/gufic-biosciences-limited" rel="self" type="application/rss+xml" />
    <image>
      <url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo68364afb78dffbe2df153200.webp</url>
      <title>Gufic Biosciences Limited</title>
      <link>https://6ix.com/company/gufic-biosciences-limited</link>
    </image>
    <item>
      <title>Press Release Sep 11 2023</title>
      <link>https://6ix.com/company/gufic-biosciences-limited/news/press-release-sep-11-2023-10</link>
      <guid isPermaLink="true">https://6ix.com/company/gufic-biosciences-limited/news/press-release-sep-11-2023-10</guid>
      <pubDate>Mon, 11 Sep 2023 22:32:56 GMT</pubDate>
      <description>Gufic Biosciences Limited has informed the Exchange regarding a press release dated September 11, 2023, titled &quot;Press Release   Gufic receives approval of TGA, Australia and ANVISA, Brazil for Parecoxib 40mg injection &quot;.</description>
    </item>
    <item>
      <title>Press Release Jun 16 2023</title>
      <link>https://6ix.com/company/gufic-biosciences-limited/news/press-release-jun-16-2023-9</link>
      <guid isPermaLink="true">https://6ix.com/company/gufic-biosciences-limited/news/press-release-jun-16-2023-9</guid>
      <pubDate>Fri, 16 Jun 2023 21:53:09 GMT</pubDate>
      <description>Gufic Biosciences Limited has informed the Exchange regarding a press release dated Jun 16, 2023, titled &quot;Press Release   Gufic receives approval from NMPA, China for Prilocaine API &quot;.</description>
    </item>
    <item>
      <title>Press Release May 30 2023</title>
      <link>https://6ix.com/company/gufic-biosciences-limited/news/press-release-may-30-2023-33</link>
      <guid isPermaLink="true">https://6ix.com/company/gufic-biosciences-limited/news/press-release-may-30-2023-33</guid>
      <pubDate>Tue, 30 May 2023 22:02:42 GMT</pubDate>
      <description>Gufic Biosciences Limited has informed the Exchange regarding a press release dated May 30, 2023, titled &quot;Press Release   Gufic receives DCGI nod for Dalbavancin API and formulation&quot;.</description>
    </item>
    <item>
      <title>Press Release Jun 06 2022</title>
      <link>https://6ix.com/company/gufic-biosciences-limited/news/press-release-jun-06-2022-6</link>
      <guid isPermaLink="true">https://6ix.com/company/gufic-biosciences-limited/news/press-release-jun-06-2022-6</guid>
      <pubDate>Mon, 06 Jun 2022 21:57:11 GMT</pubDate>
      <description>Gufic Biosciences Limited has informed the Exchange about press release dated 06-Jun-2022 titled Gufic Biosciences Limited eyes to grab major share of Rs. 3000 Crore Lyophilized Antibiotics and Antifungal market in India</description>
    </item>
    <item>
      <title>Press Release Apr 11 2022</title>
      <link>https://6ix.com/company/gufic-biosciences-limited/news/press-release-apr-11-2022-11</link>
      <guid isPermaLink="true">https://6ix.com/company/gufic-biosciences-limited/news/press-release-apr-11-2022-11</guid>
      <pubDate>Mon, 11 Apr 2022 21:05:16 GMT</pubDate>
      <description>Gufic Biosciences Limited has informed the Exchange about press release dated 11-Apr-2022 titled Gufic receives permission from CDSCO to manufacture and sale Isavuconazonium Sulfate API and Finished formulation Isavuconazole for Injection 200 mg/vial</description>
    </item>
    <item>
      <title>Press Release Apr 05 2022</title>
      <link>https://6ix.com/company/gufic-biosciences-limited/news/press-release-apr-05-2022-15</link>
      <guid isPermaLink="true">https://6ix.com/company/gufic-biosciences-limited/news/press-release-apr-05-2022-15</guid>
      <pubDate>Tue, 05 Apr 2022 20:00:41 GMT</pubDate>
      <description>Gufic Biosciences Limited has informed the Exchange about press release dated 05-Apr-2022 titled Gufic receives DCGI nod for Thymosin Alpha - 1</description>
    </item>
  </channel>
</rss>